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Summary
Autophosphorylation of a critical residue in the acti-
vation loop of several protein kinases is an essential
maturation event required for full enzyme activity.
However, the molecular mechanism by which this
happens is unknown. We addressed this question for
two dual-specificity tyrosine-phosphorylation-regu-
lated protein kinases (DYRKs), as they autophosphor-
ylate their activation loop on an essential tyrosine but
phosphorylate their substrates on serine and threo-
nine. Here we demonstrate that autophosphorylation
of the critical activation-loop tyrosine is intramolecu-
lar and mediated by the nascent kinase passing
through a transitory intermediate form. This DYRK in-
termediate differs in residue and substrate specificity,
as well as sensitivity to small-molecule inhibitors,
compared with its mature counterpart. The intermedi-
ate’s characteristics are lost upon completion of
translation, making the critical tyrosine autophos-
phorylation a “one-off” inceptive event. This mecha-
nism is likely to be shared with other kinases.
Introduction
Protein kinases have developed a multitude of pro-
cesses to regulate their activity. The best-understood
mechanism is phosphorylation of the kinase activation
loop (also called activation segment or T loop), re-
viewed in Johnson et al. (1996) and Nolen et al. (2004).
This can be carried out by an upstream kinase as part
of a signaling cascade, or a kinase can autophosphory-
late its own activation loop by either an inter- or in-
tramolecular mechanism. One family of kinases that
activate themselves by autophosphorylation are the dual-
specificity tyrosine-phosphorylation-regulated protein ki-
nases (DYRKs).
DYRKs are an evolutionary conserved family of pro-*Correspondence: p.lochhead@beatson.gla.ac.uk (P.A.L.); v.cleghon@
beatson.gla.ac.uk (V.C.)tein kinases that belong to the CMGC family of kinases
and are distantly related to MAPKs (mitogen-activated
protein kinases) and CDKs (cyclin-dependent protein
kinases) (Becker and Joost, 1999; Himpel et al., 2000;
Miyata and Nishida, 1999; Widmann et al., 1999). DYRK
family members share a conserved kinase domain and
adjacent N-terminal DH box (DYRK homology) but differ
in their N- and C-terminal extensions. Two DYRK sub-
classes exist. Class 1 (nuclear) DYRKs are only present
in multicellular organisms and contain an N-terminal
nuclear localization signal and a C-terminal PEST or
GAS region (regions typical in proteins targeted for
degradation). Class 2 (cytosolic) DYRKs do not contain
any other previously defined regions but are present in
all eukaryotic organisms examined to date (Lochhead
et al., 2003).
Functional studies have been conducted on yeast,
C. elegans, Drosophila, and mammalian DYRK family
members. In the yeast S. pombe, the class 2 DYRK
family member Pom1 was identified as a gene that may
be required for proper positioning of the growth and
cytokinesis machineries by interaction with both the
actin and microtubule cytoskeletons (Bahler and Prin-
gle, 1998). Experiments modifying the kinase activity of
Pom1 indicate a negative role for Pom1p in microtubule
growth at cell ends (Bahler and Nurse, 2001). Genetic
studies in C. elegans show that the only class 2 DYRK
homolog, mbk-2, is essential for the completion of cy-
tokinesis and the patterning of the first embryonic axis
during the egg-to-embryo transition (Pang et al., 2004;
Pellettieri et al., 2003; Quintin et al., 2003). In Drosoph-
ila, mutation of the founding DYRK family member,
minibrain (mnb), a class 1 DYRK, affects postembryonic
neurogenesis, resulting in specific reductions in the
size of the optic lobes and central brain hemispheres
(Tejedor et al., 1995). The human ortholog of the mini-
brain gene, DYRK1A, maps to the Down’s syndrome
critical region and is overexpressed in Down’s syn-
drome brains, suggesting a similar role for this kinase
in mammalian neurogenesis (Guimera et al., 1999).
Mice with a single copy of the DYRK1A gene display
region-specific reductions in the brain (Fotaki et al.,
2002), indicating a conserved mode of action that de-
termines normal growth and brain size in both mice
and flies.
All DYRKs autophosphorylate a critical tyrosine resi-
due in the activation loop and phosphorylate their sub-
strates on serine and threonine residues (Bahler and
Nurse, 2001; Himpel et al., 2001; Kentrup et al., 1996;
Lee et al., 2000; Lochhead et al., 2003). Biochemical
analysis of DYRK1A shows that Y321 in the activation
loop is phosphorylated (Himpel et al., 2001). This is the
second tyrosine in the sequence YXY, a motif that is
shared with all DYRK family members. There is strong
evidence that this phosphorylation is an autophosphor-
ylation event, as mutation of the Mg2+ATP-orientating
lysine in the catalytic site of both class 1 and 2 DYRKs
abolishes tyrosine phosphorylation (Bahler and Nurse,
2001; Himpel et al., 2001; Kentrup et al., 1996; Lee et
al., 2000; Lochhead et al., 2003). Bacteria do not en-
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926code tyrosine kinases (Kornbluth et al., 1988), and ex- a
mpression of DYRKs in this system produces a phos-
phorylated and active enzyme (Himpel et al., 2001; p
eKentrup et al., 1996; Lochhead et al., 2003). However,
the mechanism of autophosphorylation is not known.
In fact, the molecular mechanism of autophosphoryla- E
tion of any protein kinase is poorly understood. We b
chose to address this question for two Drosophila S
DYRKs, MNB (minibrain) and dDYRK2, representatives p
of class 1 and 2 DYRKs, respectively. Here we demon- t
strate that dDYRK2 and MNB form transitional interme- K
diates that phosphorylate Y358 or Y326 in the activa- 2
tion loop of the respective kinase domain by an i
intramolecular mechanism. Once dDYRK2 or MNB is c
fully translated and released from the ribosome, the f
transitional tyrosine-kinase activity is lost, and the t
molecules then function only as serine/threonine ki- s
nases. This is a novel mechanism by which protein e
kinases mature and explains how DYRKs autophos- t
phorylate a tyrosine residue but phosphorylate their u
substrates on serine/threonine residues. t
t
uResults
M
iIdentification of Activation-Loop Phosphorylation
sSites in dDYRK2 and MNB
KPreviously we demonstrated by mutational analysis
athat tyrosine residues in the activation loop of dDYRK2
c(i.e., Y356 and Y358) were essential for tyrosine auto-
dphosphorylation and for kinase activity (Lochhead et
ral., 2003). Comparable tyrosines exist in MNB (i.e., Y324
2and Y326), but phosphorylation of these sites has not
tbeen addressed. To identify phosphorylated residues in
tdDYRK2 and MNB, recombinant proteins were ex-
lpressed in Sf9 cells and visualized by Coomassie stain-
fing (Figure 1A). Bands corresponding to dDYRK2 and
YMNB were excised from the gel and digested with tryp-
dsin. PHOS-select beads were then used to enrich the
tphosphopeptides, and the resulting samples were ana-
plyzed by MALDI and electrospray mass spectrometry.
tThe most abundant phosphopeptides present in the
MALDI-TOF (matrix-assisted laser desorption/ioniza-
tion time-of-flight) spectra were of mass 1123.5443 m/z M
Aand 1159.5552 m/z for dDYRK2 and MNB, respectively
(data not shown). These phosphopeptide masses iden- I
ptify tryptic peptides derived from the activation loop of
dDYRK2 (IYTYIQR, amino acids 355 to 362) and MNB s
o(IYHYIQSR, amino acids 323 to 330). Fragmentation of
these peptides revealed that Y358 of dDYRK2 and Y326 S
iof MNB are phosphorylated residues (Figures 1B and
1C). This was also confirmed by inspecting the spectra a
3obtained by electrospray LC-MS/MS (liquid chromatog-
raphy-mass spectrometry/mass spectrometry) (data l
cnot shown). As no other phosphotyrosine was detected
in dDYRK2 or MNB, immunoblotting with anti-phospho- p
wtyrosine antibodies will detect only phosphorylated
Y358 in dDYRK2 and phosphorylated Y326 in MNB. B
dThe importance of Y358 in dDYRK2 was investigated
further by mutational analysis. As shown in Figure 1D, r
falteration of Y358 but not Y356 to phenylalanine abol-
ished recognition of this protein by anti-phosphotyro- t
rsine antibodies. Furthermore, phosphorylation of Y358
is required for enzyme activity, as the Y358F mutant hasn activity level equivalent to the kinase-dead K227M
utant (Figure 1D). These results demonstrate that
hosphorylation of Y358 is an essential maturation
vent required for full dDYRK2 activity.
vidence that dDYRK2 and MNB Autophosphorylate
y an Intramolecular Mechanism
everal lines of evidence indicate that tyrosine phos-
horylation of the DYRKs occurs via autophosphoryla-
ion (Bahler and Nurse, 2001; Himpel et al., 2001;
entrup et al., 1996; Lee et al., 2000; Lochhead et al.,
003). To determine if this is mediated by an inter- or
ntramolecular mechanism, we carried out a series of
oexpression experiments in Sf9 cells using mutant
orms of dDYRK2 or MNB. If phosphorylation occurs in
rans (i.e., intermolecular), then kinase-inactive ver-
ions of the molecule would be phosphorylated when
xpressed in the presence of active wt enzyme. In con-
rast, if phosphorylation occurs via a cis- or intramolec-
lar mechanism, then any mutation that compromised
he catalytic activity of the molecule would also disrupt
yrosine autophosphorylation. For these studies, we
sed kinase-inactive versions of DYRK in which the
g2+ATP-orientating lysine (K227 in dDYRK2 and K193
n MNB) located in the small lobe was altered. As
hown in Figure 2A, neither dDYRK2 K227M nor MNB
193M was tyrosine phosphorylated when expressed
lone or when coexpressed with the wt enzyme in Sf9
ells. We extended these studies by determining if wt
DYRK2 or MNB could phosphorylate a peptide of their
espective activation loop in vitro. As shown in Figure
B, both kinases efficiently phosphorylated the syn-
hetic exogenous substrate peptide Woodtide, but nei-
her dDYRK2 nor MNB phosphorylated their activation-
oop peptide. Furthermore, several different mutational
orms of dDYRK2 that are unable to autophosphorylate
358 in cis are also not phosphorylated by mature wt
DYRK2 in trans (Table 1). These results demonstrate
hat under no circumstance is intermolecular phos-
horylation observed and are consistent with DYRK au-
ophosphorylation being an intramolecular mechanism.
ature dDYRK2 and MNB Cannot
utophosphorylate on Tyrosine Residues
n our initial attempts to identify the tyrosine residues
hosphorylated in dDYRK2 and MNB, we conducted a
eries of in vitro kinase assays where either dDYRK2
r MNB was incubated in the presence of [γ-32P]ATP.
urprisingly, phosphoamino acid analysis of the result-
ng products revealed that in vitro dDYRK2 and MNB
utophosphorylate only on serine and threonine (Figure
A). These results could be explained if the activation-
oop tyrosines of dDYRK2 and MNB were stoichiometri-
ally phosphorylated in vivo such that no further phos-
hate could be incorporated. To address this model,
e first treated the kinases with lambda phosphatase.
oth dDYRK2 and MNB were found to be resistant to
ephosphorylation by phosphatase, with only a 50%
eduction for both kinases seen after 15 min and no
urther reduction up to 60 min (Figure 3B). The reduc-
ion of tyrosine phosphorylation correlates with a 50%
eduction in activity (Figure 3C), further demonstratingthat the activation-loop phosphorylation is required for
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927Figure 1. Identification of Activation-Loop
Phosphorylated Residues in dDYRK2 and
MNB
(A) Sf9 cell lysates containing FLAG-dDYRK2
or FLAG-MNB were incubated with anti-
FLAG agarose, and the resulting immuno-
complexes were subjected to SDS-PAGE
and stained with Coomassie. *, FLAG-
dDYRK2 protein; **, FLAG-MNB protein; ar-
rows, IgG.
(B and C) MALDI-MS/MS spectra of the tryp-
tic phosphopeptide IYTYIQR from dDYRK2
(B) and IYHYIQR from MNB (C). The pres-
ence of the y6 ion in both spectra indicated
that Y358 in dDYRK2 and Y326 in MNB were
the phosphorylated residues (underlined),
and the neutral loss of 243 Da (phosphotyro-
sine) between y5 and y4 provided further evi-
dence for Y326 in MNB being the phosphor-
ylated residue (C).
(D) Sf9 cell lysates containing either FLAG-
wt, K227M, Y356F, Y358F, or Y356/358F were
incubated with anti-FLAG agarose, and the
immunocomplexes were subjected to SDS-
PAGE and immunoblotted with anti-phos-
photyrosine (upper panel) or anti-FLAG anti-
bodies (lower panel).
(E) Immunocomplexes were prepared as
above, and the enzyme activity was mea-
sured using Woodtide as substrate as de-
scribed in Experimental Procedures. Results
are presented as the means ± SD (n = 4).activity. However, the resistance to dephosphorylation
indicates that the phosphorylated activation-loop tyro-
sine is potentially buried in the mature kinase structure.
We next tested the ability of the dephosphorylated
DYRK molecules to rephosphorylate by incubating the
phosphatase-treated samples with [γ-32P]ATP in anin vitro kinase assay. As shown in Figure 3A, lambda-
phosphatase-treated dDYRK2 and MNB autophos-
phorylate only on serine and threonine residues. The
sample tested in this reaction contained both tyrosine-
and non-tyrosine-phosphorylated DYRK molecules.
These results therefore demonstrate that in vitro fully
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(A) FLAG-tagged versions of dDYRK2 (left panel) were expressed
salone or in combination with nontagged K227M or wt dDYRK2 as
aindicated in Sf9 cells. Or FLAG-tagged versions of MNB (right
ppanel) were expressed alone or in combination with nontagged
K193M or wt MNB as indicated in Sf9 cells. The lysates were incu- T
bated with anti-FLAG agarose and the immunocomplexes sub- d
jected to SDS-PAGE and immunoblotted with either anti-phospho- m
tyrosine (upper panel) or anti-FLAG (lower panel) antibodies. s
(B) Immunocomplexes of either FLAG-wt dDYRK2 or FLAG-wt
eMNB were incubated in either the presence or absence of 50 M
(Woodtide or 50 M of their respective activation-loop peptides,
dand activity was determined as described in Experimental Pro-
cedures. Results are presented as the means ± SD (n = 4). m
rdDYRK2 autophosphorylation on Y358 occurs while
still bound to ribosomes. These results indicate that au-phate has been removed.
Table 1. Summary of Autophosphorylation Results for dDYRK2 Mutants
Phosphorylation of Phosphorylation of Y358 In
Form of dDYRK2 Description of Form Y358 When Expressed trans by Mature dDYRK2 Figure Number
K227M Point mutation in small lobe − − Figures 1, 2, 4
D324A Point mutation in large lobe − N/T Figure 4
N and C noncatalytic Inactive kinase domain − − Data not shown
terminia
Lambda-phosphatase Removal of Y358 phosphorylation N/A − Figure 3
treated on mature kinase
Expressed with Expression of full-length − − Figure 5
purvalanol A nonphosphorylated kinase
Activation-loop peptide Consensus amino acid sequence N/A − Figure 2
lacking tertiary structure
SD IX-C-term Incomplete kinase domain − N/T Figure 4
+, phosphorylation; −, no phosphorylation; N/A, not applicable; N/T, not tested.f
mature forms of dDYRK2 and MNB cannot autophos- t
phorylate tyrosine residues by either an intra- or inter- t
molecular mechanism, even when some of the phos-a Removal of the noncatalytic N terminus abrogates Y358 autophosphorylaDYRK2 is Phosphorylated before Leaving
he Ribosome
he above results and additional observations (see Dis-
ussion) led us to speculate that the tyrosine autophos-
horylation event may be fundamentally different from
he subsequent serine/threonine phosphorylation of
ubstrates. Part of this disparity can be accounted for
y fundamental differences in intra- versus intermolec-
lar phosphorylation events. However, this explanation
oes not account for the apparent “one-off” character-
stic of tyrosine autophosphorylation. To address the
phemeral nature of this process, we employed an
n vitro translation system (rabbit reticulocyte lysate).
s shown in Figure 4A, the kinetics of dDYRK2 expres-
ion (anti-FLAG immunoblot) parallels the levels of
yrosine phosphorylation (anti-phosphotyrosine immu-
oblot). dDYRK2 expression and tyrosine phosphoryla-
ion are both first detected after 20 min. As the levels
f dDYRK2 expression increase, so to do the levels of
yrosine phosphorylation. Similar results were obtained
ith MNB (Figure 4B). The absence of any lag time be-
ween synthesis and autophosphorylation demon-
trates that the autophosphorylation event is extremely
apid, consistent with it being an intramolecular event.
One model that would account for the observed ex-
erimental results is if tyrosine autophosphorylation oc-
urred during an essential maturation process coupled
o or completed immediately after the elongation step
f protein translation. To address this, we purified ribo-
omes from rabbit reticulocyte lysate during translation
nd analyzed these samples to determine if dDYRK2
olypeptide chains were still attached to the ribosome.
he samples were immunoblotted for both the nascent
DYRK2 chains and their phosphotyrosine status. Im-
unoblotting for the ribosomal protein L11 demon-
trates that centrifugation through a sucrose cushion
nriched for ribosomes compared with the supernatant
Figure 4C, lower panel); furthermore, wt and K227M
DYRK2 were copurified with the ribosomes (Figure 4C,
iddle panel). Wild-type but not K227M dDYRK2 is ty-
osine phosphorylated to a level equivalent to that of
ully translated and released wt dDYRK2 detected in
he FLAG-immunoprecipitated sample of the superna-
ant (Figure 4C, upper panel). This indicates thattion (data not shown).
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929Figure 3. Mature dDYRK2 and MNB Do Not Autophosphorylate on Tyrosine
(A) Immunocomplexes of FLAG-wt dDYRK2 (left panel) or FLAG-wt MNB (right panel) were incubated in the presence or absence of lambda
phosphatase for 30 min and then allowed to autophosphorylate in the presence of [γ-32P]ATP. The proteins were then subjected to SDS-PAGE
and transferred to PVDF membranes. 32P-labeled FLAG-dDYRK2 and FLAG-MNB were excised from the filter, hydrolyzed, and normalized
for counts, and the amino acids were separated by TLC. Ninhydrin was used to visualize amino acids, and autoradiography was used to
visualize phosphorylated amino acids. An overlay of these images shows which amino acids are phosphorylated.
(B) Sf9 cell lysates containing either FLAG-dDYRK2 (left panel) or FLAG-MNB (right-panel) were incubated with anti-FLAG agarose, and the
immunocomplexes were treated with lambda phosphatase for the times indicated, subjected to SDS-PAGE, and immunoblotted with anti-
phosphotyrosine (upper panel) or anti-FLAG antibodies (lower panel).
(C) Immunocomplexes were prepared as above and treated with lambda phosphatase for 30 min, and the enzyme activity was measured
using Woodtide as substrate as described in Experimental Procedures. Results are presented as the means ± SD (n = 4).tophosphorylation occurs at dDYRK2’s inception and
suggest the existence of a maturational intermediary
capable of tyrosine autophosphorylation.
dDYRK2 Requires a Fully Translated and Functional
Kinase Domain for Autophosphorylation
To address the catalytic properties of the intermediate
form of the dDYRK2 kinase domain, we generated vari-
ous C-terminal-deletion mutants. As proteins are trans-
lated from N to C terminus, we inserted stop codons in
between the various kinase subdomains, starting after
subdomain VIII, where Y358 is situated. A schematic
diagram of the truncated molecules is outlined in Figure
4D. The FLAG-tagged truncated molecules were ex-
pressed in the rabbit reticulocyte system, immunopre-
cipitated, and immunoblotted for their expression and
their tyrosine phosphorylation status. As shown in Fig-
ure 4E, the expected sizes of molecules were detected
(lower panel). dDYRK2 autophosphorylation requires
full expression of all the canonical kinase subdomains
( C-term), as mutants lacking any of these abolish au-
tophosphorylation (SD IX-C-term, SD X-C-term, and
SD XI-C-term).It is clear that the maturation intermediary requires
the conserved Mg2+ATP-orientating lysine for auto-
phosphorylation (see above); however, it is unknown if
this form of the kinase domain requires other con-
served catalytic residues. To determine if dDYRK2
autophosphorylation requires D324, the aspartic acid in
the catalytic loop of the large lobe, we mutated this
residue to alanine and expressed it in the rabbit reticu-
locyte lysate. D324 is indeed essential for autophos-
phorylation of dDYRK2, as no phosphotyrosine is
detected in this mutant (Figure 4F). These results dem-
onstrate that the molecular mechanism of phos-
photransfer for the maturation intermediate to autophos-
phorylate is at least in part similar to the mechanism
employed by the mature form of dDYRK2 to phosphor-
ylate exogenous substrates.
Drug-Sensitivity Studies Show Fundamental
Differences in DYRK Tyrosine Autophosphorylation
and Serine/Threonine Substrate Phosphorylation
We next used the in vitro translation system to ask if
any known small-molecule inhibitors of DYRKs would
be able to block the autophosphorylation event and
Cell
930Figure 4. dDYRK2 Autophosphorylation Is Coupled to Translation
(A) FLAG-wt dDYRK2 was transcribed and translated in rabbit reticulocyte lysates for the times indicated. Samples were then incubated with
anti-FLAG agarose, and immunocomplexes were subjected to SDS-PAGE and immunoblotted with either anti-phosphotyrosine (upper panel)
or anti-FLAG (lower panel) antibodies.
(B) FLAG-wt MNB was transcribed and translated in rabbit reticulocyte lysates for the times indicated and analyzed as in (A).
(C) FLAG-wt dDYRK2 was expressed in rabbit reticulocyte lysate for 25 min, and then translation stopped. Ribosomes were purified through
a 0.5 M sucrose cushion and resuspended in sample buffer. The supernatant from the sucrose cushion was incubated with anti-FLAG agarose.
The ribosomal pellet, 5 l of neat supernatant, and the supernatant immunocomplexes were subjected to SDS-PAGE and immunoblotted
with either anti-phosphotyrosine (upper panel), anti-FLAG (middle panel), or anti-L11 (lower panel) antibodies. *, FLAG-dDYRK2; **, L11;
arrows, IgG; arrowheads, nonspecific bands.
(D) Schematic representation of kinase-subdomain (SD) deletion mutants of dDYRK2. Kinase domain is in gray with the subdomain boundaries
marked, and the domains analyzed are marked with roman numerals. The amino acid numbers of the mutants are indicated.
(E) The FLAG-tagged kinase-subdomain-deletion mutants of dDYRK2 outlined in (D) were expressed in rabbit reticulocyte lysate and prepared
as in (A).
(F) FLAG-tagged wt, K227M, and D324A were expressed in rabbit reticulocyte lysate and prepared as in (A).
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931produce non-tyrosine-phosphorylated protein. Purvala-
nol A and TBB are known inhibitors of DYRK1A (Bain
et al., 2003; Sarno et al., 2003). These small-molecule
inhibitors also inhibit dDYRK2 activity toward the exog-
enous substrate Woodtide in vitro, TBB being more
potent than purvalanol A (Figure 5A). However, only
purvalanol A but not TBB inhibits dDYRK2 autophos-
phorylation in the rabbit reticulocyte lysate (Figures 5B
and 5C). Purvalanol A can also inhibit CDKs; therefore,
to control for these kinases being involved in dDYRK2
autophosphorylation, we used alsterpaullone, a known
CDK but not DYRK inhibitor (Bain et al., 2003). Alster-
paullone had no effect on either dDYRK2 activity to-
ward Woodtide or its autophosphorylation. Further-
more, PP2, a tyrosine-kinase inhibitor (Hanke et al.,
1996), also had no effect (Figures 5D and 5E). This
provides further evidence that dDYRK2 autophosphor-
ylates in the rabbit reticulocyte lysate as well as indicat-
ing that the mechanism of dDYRK2 autophosphoryla-
tion is different from the mechanism that it uses to
phosphorylate exogenous substrates.Figure 5. The Effect of Purvalanol A and TBB
on dDYRK2 Exogenous Substrate Phos-
phorylation and Nascent Kinase Autophos-
phorylation
(A) FLAG-wt dDYRK2 was preincubated in
the presence or absence purvalanol A or
TBB at the concentrations indicated for 30
min on ice. Kinase activity was measured
against Woodtide as described in Experi-
mental Procedures. Results are presented as
the means ± SEM (n = 3).
(B) FLAG-wt dDYRK2 was expressed in rab-
bit reticulocyte lysate in the presence of pur-
valanol A at the concentrations indicated
and then incubated with anti-FLAG agarose.
The immunocomplexes were subjected to
SDS-PAGE and immunoblotted with either
anti-phosphotyrosine (upper panel) or anti-
FLAG (lower panel) antibodies.
(C) FLAG-wt dDYRK2 was expressed in rab-
bit reticulocyte lysate in the presence of TBB
at the concentrations indicated and then
prepared as in (B).
(D) FLAG-wt dDYRK2 was preincubated in
the presence or absence of 100 M alster-
paullone or PP2 for 30 min on ice. Kinase
activity was measured against Woodtide as
described in Experimental Procedures. Re-
sults are presented as the means ± SEM
(n = 3).
(E) FLAG-wt dDYRK2 was expressed in rab-
bit reticulocyte lysate in the presence or ab-
sence of 100 M alsterpaullone or PP2 and
then prepared as in (B).
(F) FLAG-wt dDYRK2 was expressed in rab-
bit reticulocyte lysate in the presence or ab-
sence of 100 µM purvalanol A and immuno-
precipitated with anti-FLAG agarose. The
immunoprecipitates were allowed to auto-
phosphorylate in the presence of [γ-32P]ATP.
The proteins were then subjected to SDS-
PAGE and transferred to PVDF membranes.
32P-labeled FLAG-dDYRK2 and FLAG-MNB
were excised from the filter, hydrolyzed, and normalized for counts, and the amino acids were separated by TLC. Ninhydrin was used to
visualize amino acids, and autoradiography was used to visualize phosphorylated amino acids. An overlay of these images shows which
amino acids are phosphorylated.Our model makes a strong prediction: drugs that in-hibit autophosphorylation may act irreversibly. As the
purvalanol A-treated non-tyrosine-phosphorylated DYRK
molecules represent intermediates in maturation, we
asked if they represent functional intermediates and if
the effects of purvalanol A could be reversed, allowing
DYRK to complete autophosphorylation in vitro. Figure
5F demonstrates that full-length DYRK molecules that
have never been phosphorylated as a consequence of
treatment with purvalanol A are unable to autophos-
phorylate on tyrosine. This result supports our model
that autophosphorylation of the DYRK activation-loop
tyrosine is accomplished by the action of a transitional
intermediate and is a one-off event.
Discussion
We initiated these studies to answer two questions
concerning the regulation of DYRK catalytic activity.
First, how does a serine/threonine kinase autophos-
phorylate on tyrosine residues? And second, why are
DYRK proteins unable to phosphorylate these same ty-
rosine residues in vitro?
Cell
932Here we suggest that a canonical kinase domain can t
padopt a functional intermediate during maturation of
the enzyme that is capable of intramolecular phospho- i
stransfer. As proteins are translated, the N terminus
becomes available for folding before the C terminus, t
lleading to the formation of folded translational interme-
diates typically consisting of w50–300 amino acids. u
sCertain intermediates have been shown to exhibit tran-
sient properties that differ from the full-length protein. s
iOnce translation is complete, proteins then assume
their mature conformation (Fedorov and Baldwin, 1997). t
dWe postulate that the existence of an intramolecular
transitional intermediate provides the simplest explana- i
(tion for the observed behavior of DYRK proteins (Figure
6), based on the following evidence. First, full-length 1
tdephosphorylated (phosphatase-treated) or nonphos-
phorylated (purvalanol A-expressed) DYRKs cannot re- t
aphosphorylate the activation-loop tyrosine, but newly
synthesized kinase can, in parallel with translation. t
vSecond, purification of ribosome bound nascent tyro-
sine-phosphorylated DYRK polypeptides demonstrates a
tthat DYRK tyrosine autophosphorylation occurs prior to
disengagement from the ribosome. Third, the functional a
cDYRK intermediate formed during translation has dif-
ferent residue and substrate specificities, as well as dif-
aferent sensitivities to small-molecule inhibitors, com-
pared to its mature counterpart. For example, the s
tdDYRK2 transitional intermediate phosphorylates a ty-
rosine residue in the sequence KIYTYI (where the un- p
iderlined residue is phosphorylated), compared to the
mature kinase that phosphorylates a serine or threonine r
fresidue in the preferred substrate sequence, R(X)XS/TP
(Campbell and Proud, 2002). We believe that it is the e
iintramolecular nature of the reaction that accounts for
differences in residue and substrate specificities, for, as iFigure 6. Model of the Mechanism of DYRK
Autophosphorylation
As DYRK mRNA is translated, the N-terminal
polypeptide begins to form secondary and
tertiary structure (I). During folding of the
polypeptide, an intermediate is formed, and
the activation loop is the first substrate seen
by the nascent kinase domain (II). The inter-
mediate possesses tyrosine-kinase activity
that phosphorylates the critical activation-
loop tyrosine (III). The fully translated and ac-
tivation-loop phosphorylated DYRK is now in
its mature conformation. The tyrosine-kinase
activity is lost, and the kinase functions as a
serine/threonine kinase (IV). The residue and
substrate specificities and sensitivities to
small-molecule inhibitors are outlined below.the protein matures, the first substrate encountered ishe molecule’s own activation-loop region, and phos-
horylation of the second tyrosine in the YXY motif is
nevitable. While many studies have concentrated on
pecificity determinants of intermolecular phosphoryla-
ion events, we know of none that addresses intramo-
ecular constraints. Our work suggests that intramolec-
lar determinants will differ not only with respect to
urrounding consensus sequences but even with re-
pect to the amino acid phosphorylated. The difference
n sensitivity to two structurally distinct chemical inhibi-
ors (TBB and purvalanol A) suggests that there are
ifferences in the folded structure of the transitional
ntermediate compared with the mature kinase. TBB
Szyszka et al., 1995) and purvalanol A (Gray et al.,
998) are structurally distinct ATP-competitive inhibi-
ors, with purvalanol A being the significantly larger of
he two. Therefore, it is conceivable that the intermedi-
te forms a different kinase structure that is only sensi-
ive to the larger of the two molecules, or that noncon-
entional inhibitor:protein interactions are formed that
re not conserved in the mature kinase. These results,
aken together, indicate that the transitional intermedi-
te kinase domain has a functionally different structure
ompared with its mature counterpart.
Autophosphorylation by a transitional intermediate is
previously unrecognized aspect of protein-kinase
tructure and function that is unlikely to be unique to
he DYRK family of protein kinases. For instance, auto-
hosphorylation of the serine/threonine kinase GSK3β
s intramolecular (Cole et al., 2004) and on a tyrosine
esidue (Y216) whose surrounding sequence differs
rom its substrate phosphorylation sequence (Hughes
t al., 1993). In addition, no phosphate is incorporated
nto tyrosine when GSK3 isolated from mammalian cells
s incubated with Mg2+ATP (Hughes et al., 1993) Al-
though there is some evidence for rephosphorylation of
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cient than autophosphorylation of newly synthesized
kinase and highlights GSK3 as a kinase that, like
DYRKs, may autophosphorylate by passing through a
maturational intermediate.
Another candidate is ERK7, a member of the MAPK
family of protein kinases (Abe et al., 1999). ERK7 is con-
stitutively active and autophosphorylates by an intra-
molecular mechanism on its TEY motif in the activation
loop (which is shared with all MAPK family members)
(Abe et al., 2001). The consensus phosphorylation se-
quence for ERK7 substrates is not known; however,
other ERKs are serine/threonine kinases, suggesting
that the tyrosine autophosphorylation mechanism
could be the same as described here for the DYRKs.
The potential of kinases to autophosphorylate by a
transitional intermediate is not limited to phosphoryla-
tion of tyrosine residues. Kinases that are constitutively
phosphorylated on serine or threonine residues in the
activation loop include the cAMP-activated protein ki-
nase (PKA). PKA is a holoenzyme composed of two ca-
talytic and two regulatory subunits. Catalytic subunits
isolated from animal cells are fully phosphorylated on
the activation-loop residue T197, after which the sub-
units are assembled to give the mature holoenzyme
(Smith et al., 1999). PKA can autophosphorylate on
T197 when expressed in bacterial cells, while expres-
sion of PKA in the presence of H-89 (a small-molecule
inhibitor of PKA) produces catalytic subunits that are
not phosphorylated on T197 and are unable to rephos-
phorylate (Steinberg et al., 1993), reminiscent of results
observed with purvalanol A-expressed dDYRK2. Al-
though controversy exists as to the kinase responsible
for phosphorylation of T197 (Cauthron et al., 1998;
Moore et al., 2002), it is likely that autophosphorylation
may be the major route of T197 phosphorylation (Cheng
et al., 1998; Williams et al., 2000). We propose that this
phosphorylation may use a maturational intermediate
form of PKA, in a mechanism similar to that of DYRKs.
The molecules listed here are by no means exclusive,
and examples of other protein kinases that activate
using this mechanism remain to be identified.
Kinases that are autophosphorylated by a maturation
intermediate are likely to have developed additional
mechanisms to regulate their activity. For example, they
may only be expressed when and where they are re-
quired, and the synthesis and degradation of the kinase
may be extremely important. This seems be the case
for DYRK1A/MNB, as its expression in the developing
nervous system is only at specific times (Hammerle
et al., 2002; Hammerle et al., 2003a). Furthermore,
DYRK1B expression alters during the cell cycle (Lee et
al., 2000). Other possibilities include inhibitory phos-
phorylations on other regions of the kinase, such as the
S9 phosphorylation site in GSK3β, which inhibits the
kinase’s activity in a reversible manner (Cross et al.,
1995). Or, the kinase’s activity could be regulated by
other proteins, such as the catalytic subunits of PKA
interacting with its regulatory subunits (Smith et al.,
1999).
Protein kinases are attractive targets for therapy of
many diseases. DYRK1A is overexpressed in Down’s
syndrome, and this is thought to be responsible for
many of the developmental defects associated with thedisorder, reviewed in Hammerle et al. (2003b). Thus, in-
hibiting DYRK1A kinase activity may be a good target
for this disease. Also, overexpression of DYRK1A
(de Wit et al., 2002), DYRK1B (Lee et al., 2000), and
DYRK2 (Miller et al., 2003) has been observed in various
types of cancer, although it is not known what role
these DYRKs play in the etiology of the disease. It will
be of interest to determine if some of the cellular effects
demonstrated by purvalanol A, such as cell cycle arrest
and cell death (Villerbu et al., 2002), may be through
inhibition of DYRKs.
The identification of the one-off nature of protein-
kinase maturation intermediates highlights that DYRKs
and other kinases that activate in this way can be tar-
geted at two levels, the transitory intermediate and the
mature active enzyme. Purvalanol A is a known inhibitor
of the mature form of DYRKs, but we have shown that
it can also prevent the activation of the kinase by block-
ing autophosphorylation. Similar results were seen for
MNB in the rabbit reticulocyte lysate system (results
not shown), implying that this sensitivity is shared by
all DYRK family members. Transitory intermediates also
provide opportunities for intervention that are not pre-
sented by the mature enzyme. Some inhibitors may be
specific to the transitional event and may not be re-
vealed by screens on mature molecules, while a pos-
sible transitional requirement for additional proteins,
such as molecular chaperones, may offer novel targets
for therapy.
In conclusion, recognition of intramolecular auto-
phosphorylation mediated by a transitional intermedi-
ate form of the DYRK protein kinases demonstrates
that at least a subset of these highly studied proteins
have additional activation mechanisms and adopt alter-
native transient functional structures from the same
polypeptide chain as their mature counterpart. A major
challenge in the future will be to visualize this transi-
tional intermediate kinase form.
Experimental Procedures
Materials
The pBluescript containing the MNB cDNA was provided by Fran-
cisco Tejedor (Instituto de Neurociencias, Unidad de Neurobiologia
del Desarrollo, CSIC y Universidad Miguel Hernandez, Campus de
San Juan, Alicante, Spain). Purvalanol A was obtained from Sigma.
Alsterpaullone and PP2 were obtained from Calbiochem. TBB was
a gift from Lorenzo Pinna (Venetian Institute for Molecular Medi-
cine, University of Padova, Italy). The peptides of the dDYRK2 and
MNB activation loops were synthesized by Protein and Peptide
Chemistry, Cancer Research UK, London Research Institute, Lin-
coln’s Inn Field, London). The anti-L11 antibody was provided by
Karen Vousden (The Beatson Institute for Cancer Research, Glas-
gow, United Kingdom).
Baculovirus Constructs
The generation of the FLAG-wt, K227M, and Y356/358F dDYRK2
has been described previously (Lochhead et al., 2003). The other
dDYRK2 constructs encoding amino acid point mutations and stop
codons (for deletions) were generated with the primers outlined in
Table S1 (see the Supplemental Data available with this article on-
line) using the QuikChange Site-Directed Mutagenesis Kit (Strata-
gene) according to the manufacturer’s recommendations.
For the generation of MNB-expressing baculovirus, either a NotI
site and FLAG tag were inserted into mnb cDNA immediately up-
stream of the initiating ATG with the primers outlined in Table S1
(described as above) and the NotI EcoRI fragment encoding the
Cell
934FLAG-MNB protein or the EcoRI fragment encoding MNB protein t
awas cloned into the pVL1393 baculoviral vector (BD Biosciences)
for expression in Sf9 cells. The other MNB constructs encoding
amino acid point mutations were generated with the primers out- I
lined in Table S1. I
d
fPlasmid Constructs
nThe EcoRI insert encoding the FLAG-dDYRK2 protein was sub-
1cloned into pcDNA3 for expression using T7 RNA polymerase in
Lthe Rabbit Reticulocyte Lysate TNT system (Promega). The FLAG-
pMNB-expressing plasmid was generated using the primers and
aconditions outlined above. T3 RNA polymerase was used to ex-
epress the protein in the Rabbit Reticulocyte Lysate TNT system
(Promega).
P
IIn Vitro Transcription and Translation
iThe FLAG-dDYRK2 and FLAG-MNB were expressed in the Rabbit
wReticulocyte Lysate TNT system (Promega) using either T7 or T3
SRNA polymerase, respectively, as outlined by the manufacturer, for
P45 min unless the time is indicated. For small-molecule inhibitor
dexperiments, purvalanol A, TBB, alsterpaullone, or PP2 was added
aprior to the initiation of transcription.
T
rPurification of Ribosome Bound Nascent Chains
hThe in vitro transcription and translation were carried out as above
(for 25 min (first full-length chains begin to appear). The reaction
Twas stopped by adding 50 l of ice-cold 2× buffer C (100 mM Tris-
pHCl [pH 7.5], 2 mM EDTA, 2 mM EGTA, 100 mM NaF, 10 mM NaPPi,
a2 mM NaOVa4, and 2× Complete minitab protease inhibitor). Fifty
fmicroliters of the stopped reaction was placed on top of 150 l
w0.5 M sucrose cushion in buffer C and spun at 100,000 rpm for 6
wmin at 4°C in a Beckman TLA-100.3 rotor. The pellet was washed
twice in buffer B and resuspended in sample buffer.
P
IImmunoprecipitation of dDYRK2 or MNB
uSf9 cell extract (0.15 mg) or rabbit reticulocyte lysate was incu-
tbated for 1 hr on a rotating platform with anti-FLAG agarose. The
timmunocomplex was pelleted and washed twice with 1 ml of ice-
Qcold buffer A (20 mM Tris-HCl [pH 8], 50 mM NaF, 500 mM NaCl,
e1 mM sodium vanadate, 1% [v/v] NP-40, 5 mM sodium pyrophos-
nphate, 10% [v/v] glycerol, and 0.1% [v/v] 2-mercaptoethanol) and
otwice with 1 ml of ice-cold buffer B (50 mM Tris-HCl [pH 7.5], 0.1
3mM EGTA, and 0.1% [v/v] 2-mercaptoethanol).
SIdentification of Phosphorylated Residues
A
Immunoprecipitated dDYRK2 or MNB was subjected to SDS-PAGE
(4%–12% NuPAGE) and stained using Simply Blue Safe Stain (Invit-
rogen). The excised proteins were alkylated with 4-vinylpyradine S
and digested with 5 g/ml trypsin in 20 mM ammonium bicarbon-
S
ate/0.1% (w/v) N-octyl glucoside (Calbiochem). The peptides were
a
extracted from the gel with addition of 60 l acetonitrile, and the
supernatant was dried in a speedvac and then resuspended in 80 A
l buffer D (30% acetonitrile/0.25 M acetic acid). The sample was
then incubated for 45 min with the addition of 20 l buffer D con-
W
taining 3 l PHOS-select beads. The beads were collected onto a
a
C 18 Zip-Tip, washed three times with 25 l buffer D, eluted with
o
2 × 25 l 0.4 M NH4OH, dried, and reconstituted in 10 l 50% ace- d
tonitrile/0.1% TFA. 0.5 l of the sample was analyzed on a 4700
Proteomics Analyzer (Applied Biosystems, Foster City, California)
Rin MS and MS/MS modes (1 KeV plus air in CID). Further analysis
Rwas performed by LC-MS/MS on a Q-TOF2 mass spectrometer
A(Micromass, Manchester, United Kingdom) as described previously
P(Way et al., 2002). Sites of phosphorylation were assigned by man-
ual inspection of resultant MS/MS spectra as well as by database
Rsearching using the Mascot (Matrixscience) search engine run on
an in-house server.
A
ELambda-Phosphatase Treatment
CImmunoprecipitated dDYRK2 or MNB was incubated in a total vol-
aume of 50 l containing 50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 0.1
mM MnCl2, 0.1 mM EGTA, 2 mM dithiolthreitol, 0.01% BRIJ 35, and A
R400 U lambda phosphatase for 30 min at 30°C. The reaction wasterminated by washing twice with 1 ml of ice-cold buffer A andwice with 1 ml ice-cold buffer B. Control reactions were performed
s above but in the absence of phosphatase.
mmunoblotting
mmunoprecipitated dDYRK2 or MNB or ribosome-purified
DYRK2 was subjected to SDS-PAGE (4%–12% NuPAGE), trans-
erred to nitrocellulose, blocked with 3% BSA TBS-T, and immu-
oblotted with either 1:15,000 dilution of anti-phosphotyrosine,
:5,000 dilution of anti-FLAG antibody, or 1:1,000 dilution of anti-
11 antibody. HRP-conjugated anti-mouse was used to detect anti-
hosphotyrosine or anti-FLAG antibody, and HRP-conjugated
nti-rabbit was used to detect anti-L11, then visualized using the
nhanced chemiluminescence system (Amersham).
hosphoamino Acid Analysis
mmunoprecipitated FLAG-dDYRK2 or FLAG-MNB was incubated
n buffer B with 100 M [γ-32P]ATP (2 × 106 cpm/nmol) for 30 min
ith agitation. The 32P-labeled dDYRK2 or MNB was subjected to
DS-PAGE as described above. The protein was transferred to
VDF Hybond-P membrane (Amersham) and visualized by autora-
iography. The radioactive band was excised from the membrane
nd the protein hydrolyzed in 6 N HCl (Aristar) at 110°C for 1 hr.
he resulting supernatant was dried in a speedvac and the pellet
esuspended in 5–10 l distilled water. One to two microliters of
ydrolysate was mixed with 1 l of phosphoamino acid standards
1 mg/ml of phospho-S, phospho-T, and phospho-Y in a 1:1:1 ratio).
he amino acids were separated on a plastic-backed TLC cellulose
late (Merck) using fresh buffer containing 1.5 M glacial acetic
cid/0.017% (v/v) formic acid/0.003% (v/v) pyridine/0.33 mM EDTA
or 1 hr at 300 V. To visualize the amino acid standards, the plate
as sprayed with ninhydrin (BDH), and 32P-labeled amino acids
ere visualized by autoradiography.
eptide Kinase Assay
mmunoprecipitated FLAG-dDYRK2 or FLAG-MNB was assayed
sing 50 M Woodtide (UBI) or 50 M activation-loop peptide with
wo additional lysines attached to the N terminus to allow it to bind
o P81 paper (KKSSCYVDRKIYTYIQSRFY for dDYRK2 or KKSSC
LGQRIYHYIQSRFY for MNB) as described previously (Lochhead
t al., 2003). For experiments with small-molecule inhibitors, immu-
oprecipitated dDYRK2 or MNB was preincubated in the presence
r absence of 10 M purvalanol A, TBB, alsterpaullone, or PP2 for
0 min on ice, then assayed as outlined above.
tatistical Analysis
ll statistical analysis was performed using Microsoft Excel 2002.
upplemental Data
upplemental Data include one table and are available with this
rticle online at http://www.cell.com/cgi/content/full/121/6/925/DC1/.
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